Screening and Diagnosis of Type 2 Diabetes in Sickle Cell Disease

References

1. 1.↵
   1. Rees DC,
   2. Williams TN,
   3. Gladwin MT

   . Sickle-cell disease. Lancet 2010;376:2018–31.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Pecker LH,
   2. Lanzkron S

   . Sickle cell disease. Ann Intern Med 2021;174:ITC1–ITC16. [Epub 19 January 2021].

   OpenUrlPubMed
3. 3.↵
   1. Lanzkron S,
   2. Strouse JJ,
   3. Wilson R,
   4. et al

   . Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Ann Intern Med 2008;148:939–55.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Niihara Y,
   2. Miller ST,
   3. Kanter J

   , Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Diseaseet al. Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease. A phase 3 trial of L-glutamine in sickle cell disease. N Engl J Med 2018;379:226–35.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Ataga KI,
   2. Kutlar A,
   3. DeBonnett L,
   4. et al

   . Crizanlizumab treatment is associated with clinically significant reductions in hospitalization inpatients with sickle cell disease: results from the SUSTAIN study. Blood 2019;134:2289–2289.

   OpenUrl
6. 6.↵
   1. Vichinsky E,
   2. Hoppe CC,
   3. Ataga KI

   , HOPE Trial Investigatorset al. HOPETrial Investigators. A phase 3 randomized trial of voxelotor in sickle cell disease. N Engl J Med 2019;381:509–19.

   OpenUrlPubMed
7. 7.↵
   1. Hulbert ML,
   2. Shalini S

   . Hematopoietic stem cell transplantation for sickle cell disease: progress and challenges. Pediatr Blood Cancer 2018;65:e27263.

   OpenUrlPubMed
8. 8.↵
   1. Tomic D,
   2. Shaw JE,
   3. Magliano DJ

   . The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol 2022;18:525–39.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Zhou J,
   2. Han J,
   3. Nutescu EA,
   4. et al

   . Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis. Br J Haematol 2019;185:116–27.

   OpenUrlPubMed
10. 10.↵
    1. Skinner S,
    2. Nader E,
    3. Connes P

    . Type 2 diabetes in adults with sickle cell disease: can we dive deeper? Br J Haematol 2019;186:783–5.

    OpenUrlPubMed
11. 11.↵
    1. Little RR,
    2. Rohlfing C,
    3. Sacks DB

    . The National Glycohemoglobin Standardization Program: over 20 years of improving hemoglobin A1c measurement. Clin Chem 2019;65:839–48.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    Sickle cell trait and other hemoglobinopathies and diabetes management. NIDDK. Epub Oct 2020. Available at: https://www.niddk.nih.gov/health-information/professionals/clinical-tools-patient-management/diabetes/sickle-cell-trait-hemoglobinopathies-diabetes?utm_source=copy&utm_medium=sharing+button&utm_content=%2Fhealth-information%2Fprofessionals%2Fclinical-tools-patient-management%2Fdiabetes%2Fsickle-cell-trait-hemoglobinopathies-diabetes.
13. 13.↵
    1. Davidson KW,
    2. Barry MJ,
    3. Mangione CM

    , US Preventive Services Task Forceet al. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326:736–43.

    OpenUrlCrossRefPubMed
14. 14.↵
    The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34.

    OpenUrlFREE Full Text
15. 15.↵
    American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 2022;45:S17–S38.

    OpenUrlCrossRefPubMed
16. 16.
    1. Parrinello CM,
    2. Selvin E

    . Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep 2014;14:548.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Welsh KJ,
    2. Kirkman MS,
    3. Sacks DB

    . Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions. Diabetes Care 2016;39:1299–306.

    OpenUrlFREE Full Text